Literature DB >> 19094819

Antimicrobial therapy for bone and joint infections.

Saima Aslam1, Rabih O Darouiche.   

Abstract

Bone and joint infections present a major therapeutic dilemma for health care providers from different medical and surgical specialties. There is a conspicuous lack of strong data on epidemiologic findings, financial impact related to loss of work, and rehabilitation cost in the area of bone infections. This review outlines the antimicrobial options and duration of therapy for osteomyelitis, prostheses-associated orthopedic infections, and septic arthritis.

Entities:  

Year:  2009        PMID： 19094819     DOI： 10.1007/s11908-009-0002-x

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


  48 in total

1.  BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults.

Authors:  G Coakley; C Mathews; M Field; A Jones; G Kingsley; D Walker; M Phillips; C Bradish; A McLachlan; R Mohammed; V Weston
Journal:  Rheumatology (Oxford)       Date:  2006-07-06       Impact factor: 7.580

2.  Linezolid in the treatment of Gram-positive prosthetic joint infections.

Authors:  Matteo Bassetti; Francesco Vitale; Giovanna Melica; Elda Righi; Antonio Di Biagio; Luigi Molfetta; Francesco Pipino; Mario Cruciani; Dante Bassetti
Journal:  J Antimicrob Chemother       Date:  2005-02-10       Impact factor: 5.790

3.  Combination of quinupristin-dalfopristin (Synercid) and rifampin is highly synergistic in experimental Staphylococcus aureus joint prosthesis infection.

Authors:  Azzam Saleh-Mghir; Nourdine Ameur; Claudette Muller-Serieys; Farid Ismael; Françoise Lemaitre; Laurent Massias; Céline Feger; Rémy Bléton; Anne-Claude Crémieux
Journal:  Antimicrob Agents Chemother       Date:  2002-04       Impact factor: 5.191

4.  Infectious arthritis.

Authors:  J T Sharp; M D Lidsky; J Duffy; M W Duncan
Journal:  Arch Intern Med       Date:  1979-10

5.  Risk factors for prosthetic joint infection: case-control study.

Authors:  E F Berbari; A D Hanssen; M C Duffy; J M Steckelberg; D M Ilstrup; W S Harmsen; D R Osmon
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

6.  Conservative medical therapy of prosthetic joint infections: retrospective analysis of an 8-year experience.

Authors:  G L Pavoni; M Giannella; M Falcone; L Scorzolini; M Liberatore; B Carlesimo; P Serra; M Venditti
Journal:  Clin Microbiol Infect       Date:  2004-09       Impact factor: 8.067

7.  Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus.

Authors:  W Zimmerli; R Frei; A F Widmer; Z Rajacic
Journal:  J Antimicrob Chemother       Date:  1994-05       Impact factor: 5.790

8.  Linezolid in the treatment of osteomyelitis: results of compassionate use experience.

Authors:  C R Rayner; L M Baddour; M C Birmingham; C Norden; A K Meagher; J J Schentag
Journal:  Infection       Date:  2004-02       Impact factor: 3.553

9.  Experimental osteomyelitis. IV. Therapeutic trials with rifampin alone and in combination with gentamicin, sisomicin, and cephalothin.

Authors:  C W Norden
Journal:  J Infect Dis       Date:  1975-11       Impact factor: 5.226

10.  Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials.

Authors:  Eirinaios M Karamanis; Dimitrios K Matthaiou; Lampros I Moraitis; Matthew E Falagas
Journal:  Spine (Phila Pa 1976)       Date:  2008-05-01       Impact factor: 3.468
View more
  3 in total

1.  Vancomycin containing PLLA/β-TCP controls MRSA in vitro.

Authors:  Berna Kankilic; Erdal Bayramli; Emine Kilic; Sezin Dağdeviren; Feza Korkusuz
Journal:  Clin Orthop Relat Res       Date:  2011-09-15       Impact factor: 4.176

2.  Tetracycline tethered to titanium inhibits colonization by Gram-negative bacteria.

Authors:  Helen Davidson; Martin Poon; Ray Saunders; Irving M Shapiro; Noreen J Hickok; Christopher S Adams
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2014-11-12       Impact factor: 3.368

3.  Epidemiology of septic arthritis of the knee at Hospital das Clínicas, Universidade de São Paulo.

Authors:  Camilo Partezani Helito; Guilherme Guelfi Noffs; Jose Ricardo Pecora; Riccardo Gomes Gobbi; Luis Eduardo Passarelli Tirico; Ana Lucia Munhoz Lima; Priscila Rosalba de Oliveira; Gilberto Luis Camanho
Journal:  Braz J Infect Dis       Date:  2013-09-09       Impact factor: 3.257
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.